The investigator goal is to develop a commercial instrument for measuring and characterizing intrinsic fluorescence (autofluorescence) in the retina. This instrument will make it possible to broaden the research connecting lipofuscin - the dominant retinal fluorophore - with aging, age related macular degeneration (AMD), and several juvenile retina degenerations. Lipofuscin also is thought to reflect oxidative damage to the retina and its quantification would provide a cumulative index of oxidative damage to the retina. The Pi sees a market for such a device among retinal researchers and pharmaceutical companies. Furthermore, an instrument designed specifically for retinal spectrofluorometry will allow the study of other retial fluorophores (collagen, drusen, flavi proteins) as well as open the possibility of quantitative studies using exogenous fluorescent markers (fluorescein , ICG, BPD, etc).

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY012184-01
Application #
2651389
Study Section
Special Emphasis Panel (ZRG1-VISA (02))
Project Start
1998-04-15
Project End
1999-09-16
Budget Start
1998-04-15
Budget End
1999-09-16
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Ocumetrics, Inc.
Department
Type
DUNS #
807960844
City
Mountain View
State
CA
Country
United States
Zip Code
94043